Keyword: University of Pennsylvania
Amicus plans to build an R&D center in the heart of Philadelphia’s University City, not long after inking a $100 million deal for 10 gene therapies.
Passage Bio reeled in $115.5 million, which will support the development of five programs aimed at treating rare monogenic central nervous system diseases.
A Penn team used gene editing to screen for harmful variants of a gene that causes severe hypertrophic cardiomyopathy.
A disruption of the biological clock and obesity's "signature" on the gut microbiome could explain obesity, a study has found.
Antimalarial drugs known as chloroquines play a role in inhibiting cancer cell growth by targeting the enzyme PPT1, researchers discovered.
The pact tasks Weissmann’s UPenn lab with taking vaccines against up to 10 infectious diseases through to the completion of IND-enabling studies.
Recent biotech developments include improved viral delivery vehicles for gene therapy and compounds that cripple resistant bacteria.
Two separate teams used modified versions of CRISPR-Cas9 to correct rare but lethal inherited liver diseases.
Recent biotech discoveries include a sensory protein at the heart of hearing and new insights into how CAR-T design affects cancer treatments.
PARP inhibitors prevent the misplacement of a specific protein that has been implicated in ALS, new research shows.